Invesaro

Stocks Comparison

Davita vs Viemed Healthcare: revenue, profit, margins and growth compared

Davita brought in $13.6B of revenue in fiscal 2025, Viemed Healthcare $270.3M in fiscal 2025. Revenue changed by +6.5% at Davita and +20.5% at Viemed Healthcare on the year before, so Viemed Healthcare grew faster. Davita kept 5.5% of its revenue as net profit, Viemed Healthcare 5.5%. Free cash flow was $1.3B at Davita and $11.9M at Viemed Healthcare.

Side by side, latest fiscal year

DVAVMD
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$13.6B$270.3M
Revenue growth+6.5%+20.5%
Net income$746.8M$14.9M
Net margin5.5%5.5%
Free cash flow$1.3B$11.9M
Free cash flow margin9.6%4.4%
Earnings per share (diluted)$9.84$0.37
Cash$676.4M$13.5M
Debt$10.3B$12.4M
Price to earnings18.124.1
Market value$11.4B$339.4M
Dividend yieldn/an/a
Rank by revenue in sector#36 of 523 · Health care#231 of 523 · Health care

Over the years

Revenue
DVA FY2018: $11.4BDVA FY2019: $11.4BDVA FY2020: $11.6BDVA FY2021: $11.6BDVA FY2022: $11.6BDVA FY2023: $12.1BDVA FY2024: $12.8BDVA FY2025: $13.6BVMD FY2019: $64.5MVMD FY2019: $80.3MVMD FY2020: $131.3MVMD FY2021: $117.1MVMD FY2022: $138.8MVMD FY2023: $183MVMD FY2024: $224.3MVMD FY2025: $270.3MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $13.6BVMD $270.3M
Net income
DVA FY2018: $159.4MDVA FY2019: $811MDVA FY2020: $773.6MDVA FY2021: $978.5MDVA FY2022: $560.4MDVA FY2023: $691.5MDVA FY2024: $936.3MDVA FY2025: $746.8MVMD FY2019: $9.5MVMD FY2019: $8.5MVMD FY2020: $31.5MVMD FY2021: $9.1MVMD FY2022: $6.2MVMD FY2023: $10.2MVMD FY2024: $11.3MVMD FY2025: $14.9MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $746.8MVMD $14.9M
Net margin
DVA FY2018: 1.4%DVA FY2019: 7.1%DVA FY2020: 6.7%DVA FY2021: 8.4%DVA FY2022: 4.8%DVA FY2023: 5.7%DVA FY2024: 7.3%DVA FY2025: 5.5%VMD FY2019: 14.7%VMD FY2019: 10.6%VMD FY2020: 24.0%VMD FY2021: 7.8%VMD FY2022: 4.5%VMD FY2023: 5.6%VMD FY2024: 5.0%VMD FY2025: 5.5%FY18FY19FY20FY21FY22FY23FY24FY25
DVA 5.5%VMD 5.5%
Revenue growth
DVA FY2019: -0.1%DVA FY2020: +1.4%DVA FY2021: +0.6%DVA FY2022: -0.1%DVA FY2023: +4.6%DVA FY2024: +5.6%DVA FY2025: +6.5%VMD FY2019: +24.5%VMD FY2020: +63.6%VMD FY2021: -10.8%VMD FY2022: +18.6%VMD FY2023: +31.8%VMD FY2024: +22.5%VMD FY2025: +20.5%FY19FY20FY21FY22FY23FY24FY25
DVA +6.5%VMD +20.5%
Free cash flow
DVA FY2018: $784.5MDVA FY2019: $1.3BDVA FY2020: $1.3BDVA FY2021: $1.3BDVA FY2022: $961.1MDVA FY2023: $1.5BDVA FY2024: $1.5BDVA FY2025: $1.3BVMD FY2019: $16.3MVMD FY2019: $5.7MVMD FY2020: $22.1MVMD FY2021: $2.8MVMD FY2022: $4.9MVMD FY2023: $19.1MVMD FY2024: $1.3MVMD FY2025: $11.9MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $1.3BVMD $11.9M

Fiscal years as each company reports them; the two may end in different months.

Questions about Davita and Viemed Healthcare

Which is bigger by revenue, Davita or Viemed Healthcare?

Davita is bigger by revenue: $13.6B in fiscal 2025, against $270.3M for Viemed Healthcare in fiscal 2025.

Which keeps more of its revenue as profit, Davita or Viemed Healthcare?

Davita had a net margin of 5.5% in fiscal 2025; Viemed Healthcare had 5.5% in fiscal 2025.

Which grew revenue faster, Davita or Viemed Healthcare?

In their latest fiscal years revenue changed by +6.5% at Davita and +20.5% at Viemed Healthcare.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies